Cargando…
Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2
BACKGROUND & AIMS: More than half of Crohn’s disease patients develop intestinal fibrosis-induced intestinal strictures. Elafin is a human protease inhibitor that is down-regulated in the stricturing intestine of Crohn’s disease patients. We investigated the efficacy of elafin in reversing intes...
Autores principales: | Xie, Ying, Fontenot, Lindsey, Chupina Estrada, Andrea, Nelson, Becca, Wang, Jiani, Shih, David Q., Ho, Wendy, Mattai, S. Anjani, Rieder, Florian, Jensen, Dane D., Bunnett, Nigel W., Koon, Hon Wai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425040/ https://www.ncbi.nlm.nih.gov/pubmed/35840034 http://dx.doi.org/10.1016/j.jcmgh.2022.06.011 |
Ejemplares similares
-
High circulating elafin levels are associated with Crohn’s disease-associated intestinal strictures
por: Wang, Jiani, et al.
Publicado: (2020) -
Elafin inhibits obesity, hyperglycemia, and liver steatosis in high-fat diet-treated male mice
por: Wang, Jiani, et al.
Publicado: (2020) -
ADS024, a Bacillus velezensis strain, protects human colonic epithelial cells against C. difficile toxin-mediated apoptosis
por: Xie, Ying, et al.
Publicado: (2023) -
Proteolytic activation of the epithelial sodium channel (ENaC) by the cysteine protease cathepsin-S
por: Haerteis, Silke, et al.
Publicado: (2012) -
Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn’s disease, and clinical prognosis in inflammatory bowel disease
por: Tran, Diana Hoang-Ngoc, et al.
Publicado: (2017)